11/29/24 17:00 | 11/27/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 1 | S | -145 | 420.44 | 0 | 0 | | 1 | D | | | | | | | | | | | | | | |
11/22/24 18:16 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ragard John Phillip | TX | D | | 2 | M.d | 0 | 0.00 | 0 | 10 | 9 | 120 | D | | | | | | | | | | | | | | |
11/21/24 18:30 | 11/19/24 | ORKA | Oruka Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fairmount Funds Management LLC | PA | DT | | 1 | M.d | 0 | 0.00 | 0 | 160 | 5 | 3,372 | I | | | | | | | | | | | | | | |
11/19/24 16:39 | 11/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 1 | S | -812 | 81.20 | 0 | -10 | | 103 | D | | | | | | | | | | | | | | |
11/18/24 17:36 | 11/14/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 1 | S | -159 | 79.65 | 0 | -2 | | 97 | D | | | | | | | | | | | | | | |
11/12/24 17:41 | 11/8/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | 1 | S | -1,001 | 87.16 | 0 | -11 | | 611 | D | | | | | | | | | | | | | | |
11/12/24 08:01 | 11/11/24 | CLDX | Celldex Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marucci Anthony S | NJ | DO | P,CEO | 1 | P | 308 | 26.82 | 0 | 12 | 40 | 40 | D | | | | | | | | | | | | | | |
10/29/24 14:06 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Woteki Catherine E | MI | D | | 2 | M.d | 59 | 14.51 | 0 | 4 | 120 | 7 | D | | | | | | | | | | | | | | |
10/29/24 14:04 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Tobin James P | MI | D | | 2 | M.d | 59 | 14.51 | 0 | 4 | 17 | 27 | D | | | | | | | | | | | | | | |
10/29/24 14:01 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rodriguez Rafael A | MI | D | | 2 | M.d | 59 | 14.51 | 0 | 4 | 120 | 7 | D | | | | | | | | | | | | | | |
10/29/24 13:58 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Green Ronald D | MI | D | | 2 | M.d | 59 | 14.51 | 0 | 4 | 47 | 13 | D | | | | | | | | | | | | | | |
10/29/24 13:56 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Gupta Aashima | MI | D | | 2 | M.d | 56 | 14.49 | 0 | 4 | 186 | 6 | D | | | | | | | | | | | | | | |
10/29/24 13:26 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Capello Jeffrey D | MI | D | | 2 | M.d | 56 | 14.49 | 0 | 4 | 186 | 6 | D | | | | | | | | | | | | | | |
10/29/24 13:23 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Borel James C | | D | | 2 | M.d | 59 | 14.51 | 0 | 4 | 19 | 25 | D | | | | | | | | | | | | | | |
10/29/24 13:19 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | 2 | M.d | 59 | 14.51 | 0 | 4 | 15 | 31 | D | | | | | | | | | | | | | | |
10/29/24 13:15 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Rocklin Amy M | MI | O | GC | 3 | M.d | 271 | 14.43 | 0 | 19 | 377 | 24 | D | | | | | | | | | | | | | | |
10/29/24 13:11 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Naemura David H. | MI | O | CFO | 1 | M.d | 214 | 13.81 | 0 | 16 | 66 | 39 | D | | | | | | | | | | | | | | |
10/29/24 13:06 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Jones Douglas Edward | MI | O | COO | 3 | M.d | 420 | 14.38 | 0 | 29 | 70 | 71 | D | | | | | | | | | | | | | | |
10/29/24 13:01 | 10/28/24 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Adent John Edward | MI | O | CEO | 4 | M.d | 1,276 | 14.29 | 0 | 89 | 57 | 246 | D | | | | | | | | | | | | | | |
10/11/24 17:23 | 10/11/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | 2 | S | -745 | 24.83 | 0 | -30 | | 977 | D | | | | | | | | | | | | | | |
10/9/24 13:18 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Timur | IL | O | CTO | 2 | P.a | 40 | 0.2900 | 0 | 138 | 232 | 197 | D | | | | | | | | | | | | | | |
10/8/24 10:42 | 9/6/24 | NUTX | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dogan Meeshanthini | IL | DO | CEO | 4 | P | 80 | 0.2900 | 0 | 276 | 20 | 1,684 | D | | | | | | | | | | | | | | |
10/4/24 19:40 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | James Andrea S. | CA | O | CFO | 1 | P | 100 | 2.97 | 0 | 34 | | 34 | D | | | | | | | | | | | | | | |
10/4/24 19:00 | 10/2/24 | OCX | Oncocyte Corp | CA | Health | Diagn | In Vitro & In Vivo Diagnostic | Broadwood Partners, L.P. | NY | T | | 1 | P.d | 3,878 | 2.95 | 0 | 1,315 | 12 | 12,489 | M | | | | | | | | | | | | | | |
10/4/24 17:29 | 10/2/24 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dube Michael P | MA | O | VP,Chief | 1 | S | -38 | 19.01 | 0 | -2 | | 47 | D | | | | | | | | | | | | | | |
10/3/24 16:44 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vos Ellen O'Connor | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 10 | 58 | D | | | | | | | | | | | | | | |
10/2/24 18:05 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Cavanaugh Stefanie L. | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 6 | 11 | 61 | D | | | | | | | | | | | | | | |
10/2/24 17:55 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Parnell Winfred | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 10 | 56 | D | | | | | | | | | | | | | | |
10/2/24 17:39 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Herchuk Jannie Prestridge | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 8 | 17 | 57 | D | | | | | | | | | | | | | | |
10/2/24 17:19 | 9/30/24 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fralick Celeste Rachelle | TX | D | | 1 | M.d | 0 | 0.00 | 0 | 5 | 12 | 46 | D | | | | | | | | | | | | | | |
9/12/24 16:09 | 9/11/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Muzzey Dale | UT | O | Chief Sc | 1 | S | -55 | 26.17 | 0 | -2 | | 108 | D | | | | | | | | | | | | | | |
9/10/24 17:22 | 9/6/24 | CDIO | Cardio Diagnostics Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Philibert Robert | IL | DO | Chief Me | 1 | P | 10 | 0.2865 | 0 | 34 | 2 | 1,684 | I | | | | | | | | | | | | | | |
9/9/24 17:48 | 9/9/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Dreismann Heinrich | UT | D | | 1 | S | -271 | 27.05 | 0 | -10 | | 122 | D | | | | | | | | | | | | | | |
9/4/24 21:13 | 2/2/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 1 | S.a | -107 | 49.54 | 0 | -2 | | 93 | D | | | | | | | | | | | | | | |
9/4/24 20:20 | 9/1/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 0 | 22 | 1 | D | | | | | | | | | | | | | | |
9/4/24 20:03 | 9/1/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | 1 | M.d | 0 | 0.00 | 0 | 0 | 4 | 1 | D | | | | | | | | | | | | | | |
9/4/24 19:38 | 9/3/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Reitan Colleen F | UT | D | | 1 | S | -1,286 | 27.95 | 0 | -46 | | 43 | D | | | | | | | | | | | | | | |